tirzepatide gout risk GLP-1 drugs — including Ozempic and Wegovy — may be tied to a slightly higher of osteoporosis and gout, according to research presented at the American Academy of Orthopaedic Surgeons' annual meeting Long-Term Safety of Tirzepatide: What

The association can be explained by many potential factors, including low-grade systemic inflammation [23], genetic pleiotropy [24], oxidative stress [25], and use of corticosteroids [26, 27]

Because of rising Type 2 diabetes and obesity rates around the globe, semaglutide use is skyrocketing

They do not suppress natural testosterone, do not cause liver toxicity, and do not produce androgenic side effects

The exception: in March 2024, the FDA approved a supplemental indication for semaglutide 2.4 mg (Wegovy) to reduce the risk of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke in adults with established cardiovascular disease and either obesity or overweight (SELECT trial, Lincoff et al., New England Journal of Medicine 2023)

Why Your Semaglutide Dose May IncreaseAnd Why Your Price Won't As your body adapts to semaglutide and your appetite-suppression response plateaus, your prescriber may recommend dose increases to maintain clinical progress toward your weight loss goals